Similarly, the mitogen-activated protein kinase 1 (MAP3K1) gene is a serine/threonine kinase that activates mutagenic downstream signaling pathways, and its mutations have been significantly associated with luminal BC (Jerzak et al., 2018). This evidence concerns the gene MAP3K1 and breast cancer.